Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (104K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (335)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Jordan, M
Right arrow Articles by Wurm, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jordan, M
Right arrow Articles by Wurm, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 596-601

Footnote

Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation

Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation Martin Jordan , Annette Schallhorn + and Florian M. Wurm*

Genentech Inc., South San Francisco , CA 94080, USA

Received November 8, 1995; Revised and Accepted January 2, 1996

ABSTRACT

DNA-calcium phosphate co-precipitates arise spontaneously in supersaturated solutions. Highly effective precipitates for transfection purposes, however, can be generated only in a very narrow range of physico-chemical conditions that control the initiation and growth of precipitate complexes. The concentrations of calcium and phosphate are the main factors influencing characteristics of the precipitate complex, but other parameters, such as temperature, DNA concentration and reaction time are important as well. An example for this is the finding that almost all of the soluble DNA in the reaction mix can be bound into an insoluble complex with calcium phosphate in <1 min. Extending the reaction time to 20 min results in aggregation and/or growth of particles and reduces the level of expression. With improved protocols we gained better reproducibility and higher efficiencies both for transient and for stable transfections. Up to 60% of cells stained positive for [beta] -gal and transient production of secreted proteins was improved 5- to 10-fold over results seen with transfections using standard procedures. Similar improvements in efficiency (number of recombinant cell colonies) were observed with stable transfections, using co-transfected marker plasmids for selection. Transient expression levels 2 days after DNA transfer and titers obtained from stable cell lines, emerging weeks later, showed strong correlation.

INTRODUCTION

Co-precipitates composed of `calcium phosphate' (hydroxyapatite) and purified DNA have been used for >20 years for the transfer to and expression of genetic information in mammalian cells in culture ( 1 ). This technique has become one of the major methods for DNA transfer to mammalian cells. A number of papers ( 2 - 6 ) have addressed observed variability of DNA transfer and low efficiency and they usually contain specific recommendations for `optimal' procedures. However, these communications did not report on the complex relationships between different components responsible for the creation of a supersaturated status. We present here data that provide the basis for a better understanding, at the physico-chemical level, of some of the most crucial aspects concerning the formation of DNA containing precipitate complexes. We have applied gained insights in sets of transfections both for transient and stable expression of recombinant proteins. We used two popular immortalized cell lines for these studies; human embryo kidney 293 cells (HEK-293) ( 7 - 9 ) and dihydrofolate reductase-minus (DHFR-) Chinese hamster ovary cells (CHO) ( 10 - 13 ). We were able to improve the efficiency of DNA transfer and expression in both cell lines.

This paper also illustrates that a simple centrifugation-OD assay can be useful in studying kinetics and reproducibility of precipitate formation. This test provides information on the reliability of precipitate formation and gives greater assurance for successful DNA transfer to cells.

MATERIALS AND METHODS

Plasmid isolation

Propagation of AmpR plasmids were done in the bacterial strain DH5a using 50 [mu]g/ml carbenicillin in LB medium. DNA was isolated using the alkaline lysis method and was purified by double equilibrium centrifugation in CsCl-ethidium bromide gradients as described by Sambrook et al . ( 13 ).

Calcium phosphate-DNA co-precipitation

A solution of 100 [mu]l of 2.5 M CaCl 2 and the desired amount of plasmid DNA was diluted with 1/10 TE buffer (1 mM Tris-HCl, 0.1 mM EDTA, pH 7.6) to a final volume of 1 ml. One volume of this 2* Ca/DNA solution was added quickly to an equal volume of 2* HEPES solution: 140 mM NaCl, 1.5 mM Na 2 HPO 4 , 50 mM HEPES, pH 7.05 at 23oC, or alternatively phosphate-free 2* HEPES buffer was prepared and supplemented with phosphate from a 300 mM stock solution of pH 7.05 containing 195 mM Na 2 HPO 4 and 105 mM NaH 2 PO 4 . The two solutions were mixed quickly once, and added to the cell culture medium after the time frame indicated.

Centrifugation assay

Precipitate formation was confirmed and quantified by absorption at 320 nm against a blank lacking the phosphate or alternatively lacking both, DNA and phosphate. The association (binding) of DNA with precipitate was determined by OD measurement at 260 and 320 nm of a 250 [mu]l aliquot of the supernatant of the precipitation mixture after 30 s centrifugation (16 000 g ) in an Eppendorf centrifuge. The supernatant was analyzed immediately after the centrifugation step. Precautions were undertaken to prevent heating up of the rotor when multiple samples were analyzed. For precipitation experiments at 0oC the rotor was cooled down on ice before it was used.

Cell culture

Cell culture was performed according to Doyle et al. ( 21 ). Both CHO cells and 293 cells were grown in a DMEM/F12 1:1 based medium, supplemented with 2% fetal calf serum. CHO cells were maintained attached in 75 cm 2 flasks. Cells (293 HEK) were adapted to growth in suspension and grown in 250 ml spinner flasks. Both cell lines were subcultivated once or twice a week at ratios between 1:10 and 1:100.

Transient transfections

Cells from the exponential growth phase were seeded (1-4 * 10 5 cells/ml) into 12-well or 60 mm plates the day before the transfection was done. One hour before the precipitate was added, the medium was replaced with fresh medium (pH 7.4). For each ml of medium, 100 [mu]l of precipitate was added. With a calcium concentration of 125 mM in the precipitation mixture, the resulting final concentration of calcium in the cell culture medium was ~12.5 mM. The cells were exposed to the precipitate for 2-6 h at 37oC at a pH of 7.3-7.6. For CHO cells, a glycerol shock was applied at this point. The cells were exposed to 20% glycerol in PBS. After 1 min the glycerol was removed by adding fresh medium, aspiration of the mixture and replacement with fresh medium. For 293 cells the medium was replaced by fresh medium without applying a shock. The cells were then incubated for 1-6 days before the supernatant was harvested and analyzed by ELISA. Transfection efficiency was determined by staining [beta]-galactosidase expressing cells with X-Gal after 24 h ( 22 ).

Stable transfection for CHO cells

A 1:1 (w/w) mixture of linearized and purified plasmid containing DHFR as a selective marker or the TNK-tPA ( 6 ) expression cassette was precipitated as described above. The cells were grown for 2 days after transfection in non-selective medium and the supernatant was harvested to measure transient expression. The cells were trypsinized and seeded in 100 mm plates under different selective pressure. Of these cells, 2% were seeded in 100 mm plates in medium lacking glycine, hypoxanthine and thymidine (GHT- medium), 20% in GHT- medium containing 30 nM methotrexate (MTX) and 40% at 100 nM MTX. After 10 days, the product titers from pools of cells were assayed by ELISA. For each level of selective pressure, titers seen from emerging pools of stable cells were normalized against each other.

RESULTS

Complete DNA binding can be achieved within seconds upon initiation of crystal formation

Subsequent to the mixing of the calcium/DNA solution with the HEPES/phosphate solution a slight opacity appears within a few minutes, indicating that a precipitate has been formed. With the intention of having the reaction `complete', standard protocols suggest an incubation period of up to 20 ( 4 ) or even 30 min ( 3 ) at room temperature. To measure the rate at which the DNA is being incorporated into or associating with the forming precipitate an assay was developed. This test was based on a centrifugation step. The DNA concentration remaining in the clarified solutions was assessed by determining the optical density at 260 nm. Surprisingly, at a pH of 7.05 and a DNA concentration of 25 [mu]g/ml, adsorption of DNA occurred within 30 s. In fact 30 s was the shortest period for completion of this test. When either calcium or phosphate was missing in the mixture, no DNA was found to be adsorbed (data not shown).


Figure 1 . Transient expression of [beta]-gal or TNK-tPA in HEK-293 and in CHO cells transfected with a calcium phosphate-DNA precipitate complex. The precipitate was allowed to form for 1, 5 or 20 min after mixing and then added to the cells. ( A ) Cells were fixed and stained with X-gal 24 h after transfection. ( B) Supernatant was harvested and analyzed after 6 days.

Time-dependent changes in the precipitation complex that affect the efficiency for transfections

To determine the optimal incubation time for the formation of an efficient precipitate for transfections, the reaction mix was transferred to cells at different time points upon initiation of the reaction. A [beta]-galactosidase ([beta]-gal) plasmid ( 14 ) was used to estimate the number of transfected cells (transfection efficiency). An expression vector for human tissue plasminogen activator (TNK-tPA) ( 16 , 16 ) was used in a second transfection experiment.

Highest transfection efficiencies were observed with precipitation mixtures that had been incubated for short periods of time. In a representative experiment ~60% of CHO cells and 38% of HEK-293 cells stained positive for [beta]-galactosidase in plates which had been exposed to 1 min precipitate complexes (Fig. 1 A). The transfection efficiency decreased to 3-5% when precipitates were used after an incubation period of 20 min. Using a 5 min reaction time gave intermediate results. Similar differences, here in yield of a secreted protein, were observed with a transfected TNK-tPA vector (Fig. 1 B). Almost 2 [mu]g/ml for HEK-293 cells and 0.5 [mu]g/ml for CHO cells of TNK-tPA were detected by ELISA in the supernatant of cells exposed to an `early' precipitate-complex (1 min). `Late' precipitates (20 min) gave only 10% of these titers, confirming observations made by O'Mahoney et al . ( 6 ).

These differences in transfection efficiency or in the levels of secreted recombinant protein could be correlated with the nature of the calcium phosphate precipitate in plates (Fig. 2 ). Precipitates added 1 min after mixing, consisted of a large number of very small particles covering the surface of individual cells almost completely. Many particles seemed to adhere to the cells, however many were floating in the medium and exhibited Brownian motion.The large number of particles and, possibly, Brownian motion may be responsible for the image being of poor quality. Precipitate formed within a 5 min reaction time consisted of fewer but larger particles. None of these particles were floating. After 40 min the precipitate consisted of even fewer particles, some of them as big as the cells themselves. The highest transfection efficiency correlated with the generation of many very small particles.


Figure 2 . CHO cells with precipitates, visualized by phase-contrast microscopy (400* magnification) 4 h after adding the transfection cocktail to the cells. The precipitate mix was incubated for ( A ) 1, ( B ) 5 or ( C ) 40 min before transfer to the cells.

Factors affecting the kinetics of precipitate formation

Multiple transfections, done on the same day with the same solutions usually give reproducible results but the transfection efficiency can vary dramatically if experiments are performed on different days (own observations and personal communications). This provided the motivation to systematically search for parameters which affect the precipitate formation and would change the efficacy in transfections. Chen and co-authors ( 5 ) reported that the plasmid concentration needs to be optimized to achieve high transfection efficiencies. We verified this observation and found that the amount of DNA can have a major effect on the precipitation reaction (Fig. 3 A). At 25 [mu]g/ml all the DNA was bound to the forming precipitate within 1 min. Higher concentrations of DNA partially inhibited the formation of precipitates, resulting in reduced amounts of DNA being associated with an insoluble precipitate complex. A DNA concentration of 50 [mu]g/ml DNA almost completely blocked the formation of precipitates. Even after a 20 min incubation time, <20% of the DNA was associated with a precipitate.


Figure 3 . DNA binding capacity of a forming calcium phosphate precipitate at 1, 5 and 20 min. ( A ) Increasing DNA concentrations from 25 to 50 [mu]g/ml at 125 mM calcium. ( B ) Precipitation of 50 [mu]g/ml DNA at different calcium concentrations.

In an independent experiment (no temperature control) we show that increasing the calcium concentration could reverse this phenomenon. 125 mM calcium (standard) was compared with calcium concentrations of up to 250 mM (Fig. 3 B). At a concentration of 250 mM calcium twice the amount of DNA was transferred into an insoluble precipitate, almost as fast as seen under the standard calcium concentration for 25 [mu]g/ml DNA.

These data indicate that DNA participates early in the process of precipitate complex formation. The interplay of concentrations of calcium and DNA points to the possibility that DNA molecules may affect early events during nucleation and `crystal' growth.

Another important parameter is the temperature. DNA binding experiments were performed with a HEPES-phosphate buffer in which the phosphate concentration was reduced from 0.75 to 0.6 mM. Results of one of these experiments are presented here (Fig. 4 ). Under reduced phosphate concentration the rate of precipitate formation was significantly slower. The individual reactions were performed at temperatures ranging from 0 to 37oC. At 20oC, a 1 min reaction time was no longer sufficient to completely bind the DNA in solution. Even after 20 min only ~80% of the DNA was associated with a precipitate. At a temperature of 37oC, however, fast and complete removal of DNA from the solution occurred during the centrifugation step. At 0oC on the other hand, all the DNA remained in the supernatant and almost no precipitate could be detected after 20 min. This indicates a reduced solubility of calcium phosphate at elevated temperature, and it appears that relatively small variations in temperature are able to affect the kinetics of precipitate complex formation.


Figure 4 . Effect of temperature on formation of DNA-calcium phosphate precipitate complexes under a reduced phosphate concentration of 0.6 mM.

Developing an assay to quantify the precipitation step

Spontaneous precipitation occurs only if concentrations of calcium and phosphate are high enough to ensure supersaturation. All the data presented above suggest that conditions which affect the solubility of `calcium-phosphate' would directly affect the nature of the precipitate complexes. To demonstrate this we tested five different calcium concentrations between 12.5 and 250 mM in combination with 10 different phosphate concentrations between 0.15 and 6 mM and determined the quantity of DNA remaining in solution after a centrifugation step (Fig. 5 A). With a calcium concentration of 250 mM, the DNA was co-precipitated at a phosphate concentration of 0.5 mM or higher. When the calcium concentration was decreased, higher phosphate concentrations were needed to co-precipitate DNA. Precipitate-complex formation and binding of DNA could be initiated with each of the calcium concentrations used, yet at 12.5 mM calcium, the phosphate concentration had to be >= 4 mM.


Figure 5 . Effect of calcium and phosphate concentration on the precipitation of DNA (50 [mu]g DNA/ml, 23oC, pH 7.05, reaction time = 1 min). Five calcium concentrations, ranging from 12.5 to 250 mM were tested, as indicated in the figure inserts. ( A ) Soluble DNA in the supernatant as a function of the phosphate concentration. ( B ) Turbidity of the precipitation mixture (suspension) measured at 320 nm.

To assess precipitate complex formation directly, the mixture (suspension) was transferred into a spectrophotometer cuvette. The non-precipitated solutions show no absorption at 320 nm (Fig. 5 B). An increase of absorption at 320 nm indicates the appearance of a precipitate, which could be confirmed visually: the higher the phosphate concentration, the more cloudy the suspension. Increasing concentrations of phosphate resulted for each calcium-DNA mixture in a typical curve, showing increasing optical densities at higher phosphate concentrations. This assay is very reliable and gave reproducible results when performed with the same solutions repeatedly. It allows to distinguish precipitates created with different phosphate concentrations together with the same calcium and DNA solutions. It should be noted, that absorption at 320 nm is influenced by various parameters such as crystal size, particle number and structural characteristics of the precipitate complex and that an individual value does not give indications about the ratio of effects mediated by these different parameters.

Complete binding of DNA correlates with the appearance of a visible precipitate. Incomplete binding of DNA occurs in a very narrow concentration range of phosphate. While at a phosphate concentration of 0.77 mM all DNA was associated with the precipitate (at 125 mM calcium); a reduction of phosphate by 35% to 0.51 mM completely prevented binding of DNA.

In Figure 6 conditions are summarized which address incomplete binding of DNA. Concentrations of calcium and phosphate that will precipitate and bind 50% of the DNA provided were calculated from the data of Figure 5 A. These data show that the association of DNA with an emerging calcium phosphate precipitate is a function of both calcium and phosphate concentration.


Figure 6 . Relationship between calcium and phosphate concentrations sufficient to precipitate 50% of the DNA within 1 min at 23oC in a solution with 50 [mu]g/ml DNA at pH 7.05.

Correlation between precipitated DNA and levels of expression

Using the phosphate concentration as a tool to change the nature of the precipitate, we designed an experiment to correlate the optical characteristics with the transfection efficiency. Sufficient volumes of solutions were mixed to quantify the precipitation step and also to transfect two different cell lines with the same solutions on the same day in order to assess a possible correlation. While standard pH, calcium and DNA concentration were chosen for these experiments (at 23oC), the incubation time was reduced to 1 min. Shown in Figure 7 A are DNA-binding and precipitate formation as measured by absorption at 320 nm, over a range of phosphate concentrations from 0.15 to 6 mM. Corresponding transient expression levels for TNK-tPA in CHO and HEK-293 cells in relationship to the phosphate concentrations are shown in Figure 7 B.


Figure 7 . Assessment of various phosphate concentrations during the formation of a precipitate (25 [mu]g DNA/ml, 23oC, 125 mM calcium, 1 min and pH 7.05). ( A ) Quantity of soluble DNA in the supernatant after centrifugation of the precipitation mix and optical density of the precipitation mixture at 320 nm. ( B ) Transient expression levels of tPA in the supernatant of CHO or 293 HEK 42 h after transfer of the precipitation mixture to cells. The dotted vertical lines indicate concentrations of 0.5 (left) and 0.8 mM phosphate (right).Phosphate concentrations of <0.51 mM did not result in the formation of precipitates within 1 min and no transfection occurred. At a phosphate concentration of 0.63 mM, >80% of the DNA was bound to the precipitate which consisted of many very small particles. This condition also gave best transfection efficiencies for both lines. Correlating with coarser precipitates seen under the microscope, higher phosphate concentrations resulted in lower transient titers. No precipitate was detected in precipitation mixtures with 0.15 or 0.34 mM phosphate. However, in plates precipitates became visible after ~4 h. Similar precipitates were seen in plates in which the calcium concentration was raised by 12.5 mM by addition of a calcium stock solution.

Stable transfections: early `transient' titers predict number of stable clones

A series of stable transfections was performed in CHO cells. In order to facilitate the integration of plasmid DNA into the cellular genome, all plasmids were linearized by restriction enzyme digestion. A DHFR vector as a selectable marker was co-transfected together with the expression vector for TNK-tPA ( 16 ). A single plasmid mixture and cells prepared and set up on a single day were used. Transfection protocols were deliberately altered to reflect various precipitation reactions. When stable clones were selected, the number of emerging clones after the selection period of 2-3 weeks was found to be different for each type of transfection used. Most importantly, conditions that generated efficient precipitate complexes for transient expression, also resulted in the largest number of stable clones (data not shown, 17 ).

Figure 8 shows that expression levels generated transiently (2 days after exposure of DNA to the cells) correlate to the protein levels observed in pools of stable cells selected after 2 weeks. Normalized values for transient expression were plotted against normalized values representing stable expression of pools of recombinant cells, selected under three different stringency conditions: medium free of glycine, hypoxanthine and thymidine (GHT-), or GHT- media containing either 30 nM methotrexate (MTX) or 100 nM MTX. Stable titers were normalized within each selection group. The stringency of selection, as expected, affected the stable transfection efficiency (numbers of clones observed): higher selective pressure resulted in fewer clones as well as in slightly smaller colony size. Linear regression of the plotted data gave correlation coefficients of 0.83 for the values seen in the GHT- case (99% chance of correlation), 0.73 in the 30 nM MTX case (95% chance of correlation) and 0.62 in the 100 nM MTX case (90% chance of correlation). It is remarkable that the correlation for the 100 nm MTX case remained good, in spite of the fact that the individual pools of stable clones consisted of only six clones (in the one case which gave lowest transient titers) to 35 clones (in one of the transfections which gave better transient titers). Therefore, early assessment of a transfection, using the supernatant just 2 days after DNA exposure, indicates whether few or many good clones are likely to emerge weeks later.


Figure 8 . Correlation between transient and stable expression of tPA in a set of 10 independent transfections. From each plate cells were seeded in selective medium with increasing selective pressure (GHT-, 30 nM MTX and 100 nM MTX) 2 days after transfection. Transient expression levels were assessed 2 days after transfection, stable expression levels were assessed from pools of cells after 2 weeks.

DISCUSSION

The principle of the calcium-phosphate-DNA precipitation method, originally developed by Graham and Van der Eb ( 1 ), is simple. Nevertheless the formation of an optimal DNA-calcium phosphate co-precipitate is difficult to reproduce ( 18 ) because multiple parameters affect the solubility of calcium and phosphate and the appropriate window of conditions seems to be narrow.

Two interesting issues concerning the generation of a calcium phosphate-DNA precipitate complex have been discerned. An excess of soluble DNA in a supersaturated solution of calcium and phosphate may prolong the period during which a precipitate forms. If high enough in concentration, DNA may even prevent precipitate formation entirely. Therefore an error in the determination of the concentration of DNA, e.g. due to contamination with impurities which can influence the OD 260 reading might substantially affect the formation of the precipitate. The second issue is temperature: the solubility of hydroxyapatite (i.e. `calcium-phosphate') is higher at lower temperatures. Kjer et al . ( 5 ) showed that this influences transfections in mosquito cells. Although calcium phosphate is considered `insoluble' in water ( 19 ), no precipitate at all may be formed in standard mixtures at temperatures close to 0oC. Most protocols recommend `room temperature' for the preparation of the transfection mixture. Our results indicate that stricter temperature controls are appropriate for optimal results.

In order to overcome problems with the precipitation step we suggest use of simple tools for the early testing of solutions for transfections. A separate phosphate stock solution can be used for adjustment purposes. Multiple precipitations can be very consistent in terms of binding the DNA (one plasmid batch) or in terms of precipitate formation as assessed by absorption at 320 nm. Once new solutions are characterized and optimized, the precipitation procedure can be performed in a reproducible way and does not need to be re-optimized for each new transfection. New DNA preparations and new compositions ( 20 ) of supersaturated solutions can be tested quickly. The absorption at 320 nm, assessed with an aliquot of the preparation, can be used as an approach to study the kinetics and efficacy of precipitation.

The formation of the precipitate is a dynamic process which is terminated by transferring the precipitation mix into the culture medium and diluting the precipitate 10-fold. The time period allowed for generation of a precipitate is an important parameter. Subsequent to binding most of the soluble DNA into precipitate complexes, particles tend to grow further and transfection efficiency will be reduced. Theoretically, the standing time can be optimized for each set of parameters, as has been pointed out by Mahoney and Adams ( 6 ). In most cases a 1 min standing time appears to be a practical reaction time and the phosphate concentration should be used as a parameter to optimize and to control the precipitation step.

We show that concentrations of calcium, phosphate and DNA as well as temperature and reaction time affect the formation of DNA-hydroxyapatite particles in a profound way. Most importantly, transfection efficiency and expression levels in both transient and stable transfections are influenced by these parameters.

The work presented here led to research evaluating the use of calcium-phosphate for DNA transfer to cells grown in stirred laboratory bioreactors [Jordan, Köhne and Wurm (1995), submitted].

ACKNOWLEDGEMENTS

The work of M.J. was supported by the Priority Program Biotechnology (SPP), Swiss National Foundation (SNF) (grant No. 5002-38003). The work of A.S. was supported by the Carl Duisberg Gesellschaft, Ksln, Germany. The authors thank Dr Robert Arathoon for discussions and encouragement and Adriana Johnson for technical assistance.

REFERENCES

1 Graham,F.L. and Van der Eb,A.J. (1973) Virology, 52, 456-467. MEDLINE Abstract

2 Loyter,A., Scangos,G.A. and Ruddle,F.H. (1981) Proc. Natl Acad. Sci., 79, 422-426. MEDLINE Abstract

3 Graham,F.L. and Bacchetti,S. (1983) Nucleic Acid Biochem., B506, 1-14.

4 Chen,C. and Okayama,H. (1987) Mol. Cell. Biol., 7, 2745-2752. MEDLINE Abstract

5 Kjer,K.M. and Fallon,A.M. (1991) Arch. Insect Biochem. Physiol., 16, 189-200. MEDLINE Abstract

6 Mahoney,J.V. and Adams,T.E. (1994) DNA Cell Biol., 13, 1227-1232. MEDLINE Abstract

7 Paborsky,L.R., Fendly,B.M., Fisher,K.L., Lawn,R.M., Marks,B.J., McCray,G., Tate,K.M., Vehar,G.A., and Gorman,C.M. (1990) Protein Engng, 3, 547-553.

8 Pear,W.S., Nolan,G.P., Scott,M.L. and Baltimore,D. (1993) Proc. Natl Acad. Sci., 90, 8392-8396. MEDLINE Abstract

9 Gorman,C.M., Gies,D.R. and McCray,G. (1990) DNA Protein Engng Tech., 2, 1-28.

10 Urlaub,G. and Chasin,L.A. (1980) Proc. Natl Acad. Sci. 77, 4216-4220. MEDLINE Abstract

11 Ringold,G., Dieckmann,B. and Lee,F. (1981) J. Mol. Appl. Genetics, 1, 165-175.

12 Kaufman,R.J. and Sharp,P. (1982) J. Mol. Biol., 159, 601-621. MEDLINE Abstract

13 Wurm,F.M. (1990) Biologicals, 18, 159-164. MEDLINE Abstract

14 Mac Gregor,G.R. and Caskey,C.T. (1989) Nucleic Acids Res., 17, 2365. MEDLINE Abstract

15 Paoni,N.F., Keyt,B.A., Refino,C.J., Chow,A.M., Nguyen,H.V., Berlau,L.T., Badillo,J., Pena,L.C., Brady,K., Wurm F.M., Ogez,J. and Bennett,W.F. (1993) Thrombosis Haemostasis, 70, 307-312.

16 Keyt,B.A., Paoni,N.F., Refino,C.J., Berlau,L.,Nguyen,H., Chow,A., Lai,J., Pena,L., Pater,C., Ogez,J., Etcheverry,T., Botstein,D. and Bennett, W. (1994) Proc. Natl Acad. Sci., 91, 3670-3674.

17 Schallhorn,A. (1995) Report on: Practical Training Seminar at Genentech, Fachhochschule fYr Technik, Mannheim, March 1995.

18 Kingston,R.E. (1989) In: Ausuble,F., Brent,R., Kingston,R.E., Moore,D.D., Seidman,J.G., Smith,J.A., Struhl,K., (eds) Current Protocols in Molecular Biology, pp. 9.1.7-9.1.9.

19 Handbook of Chemistry and Physics, 1984 65th edition CRC press.

20 Brash,D.E., Reddel,R.R., Quanrud,M., Yang,K., Farrell,M.P. and Harris,C.C. (1987) Mol. Cell. Biol., 7, 2031-2034. MEDLINE Abstract

21 Doyle,A., Griffith,J.B. and Newell,D.G. (1994) Cell and Tissue Culture: Laboratory Procedures, Wiley, London.

22 Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.


Return

*To whom correspondence should be addressed at present address: Department of Chemistry, Swiss Federal Institute of Technology Lausanne, 1015 Lausanne, Switzerland

+ Present address: FH Mannheim, Hochschule für Technik und Gestaltung, 68163 Mannheim, Germany
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Acta Biochim Biophys SinHome page
X. Gong, W. Ye, H. Zhou, X. Ren, Z. Li, W. Zhou, J. Wu, Y. Gong, Q. Ouyang, X. Zhao, et al.
RanBPM is an acetylcholinesterase-interacting protein that translocates into the nucleus during apoptosis
Acta Biochim Biophys Sin, November 1, 2009; 41(11): 883 - 891.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Petremand, N. Bulat, A.-C. Butty, C. Poussin, S. Rutti, K. Au, S. Ghosh, V. Mooser, B. Thorens, J.-Y. Yang, et al.
Involvement of 4E-BP1 in the Protection Induced by HDLs on Pancreatic {beta}-Cells
Mol. Endocrinol., October 1, 2009; 23(10): 1572 - 1586.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. A. Spriggs, L. C. Cobbold, S. H. Ridley, M. Coldwell, A. Bottley, M. Bushell, A. E. Willis, and K. Siddle
The human insulin receptor mRNA contains a functional internal ribosome entry segment
Nucleic Acids Res., September 1, 2009; 37(17): 5881 - 5893.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
H. Ie Kim and S.-T. Lee
Oncogenic Functions of PTK6 are Enhanced by Its Targeting to Plasma Membrane But Abolished by Its Targeting to Nucleus
J. Biochem., July 1, 2009; 146(1): 133 - 139.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. W. Lai, R. A. Lew, M. A. Yarski, F.-T. Mu, R. K. Andrews, and A. I. Smith
The Identification of a Calmodulin-Binding Domain within the Cytoplasmic Tail of Angiotensin-Converting Enzyme-2
Endocrinology, May 1, 2009; 150(5): 2376 - 2381.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
W. L. Davies, L. S. Carvalho, B.-H. Tay, S. Brenner, D. M. Hunt, and B. Venkatesh
Into the blue: Gene duplication and loss underlie color vision adaptations in a deep-sea chimaera, the elephant shark Callorhinchus milii
Genome Res., March 1, 2009; 19(3): 415 - 426.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
B. El-Asmar, X. C Giner, and J. J Tremblay
Transcriptional cooperation between NF-{kappa}B p50 and CCAAT/enhancer binding protein {beta} regulates Nur77 transcription in Leydig cells
J. Mol. Endocrinol., February 1, 2009; 42(2): 131 - 138.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Wang and Q. Tong
SIRT2 Suppresses Adipocyte Differentiation by Deacetylating FOXO1 and Enhancing FOXO1's Repressive Interaction with PPAR{gamma}
Mol. Biol. Cell, February 1, 2009; 20(3): 801 - 808.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. Bulat, G. Waeber, and C. Widmann
LDLs stimulate p38 MAPKs and wound healing through SR-BI independently of Ras and PI3 kinase
J. Lipid Res., January 1, 2009; 50(1): 81 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. D. Langel, N. A. Jain, J. S. Rossman, L. M. Kingeter, A. K. Kashyap, and B. C. Schaefer
Multiple Protein Domains Mediate Interaction between Bcl10 and MALT1
J. Biol. Chem., November 21, 2008; 283(47): 32419 - 32431.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Marcellino, S. Ferre, V. Casado, A. Cortes, B. Le Foll, C. Mazzola, F. Drago, O. Saur, H. Stark, A. Soriano, et al.
Identification of Dopamine D1-D3 Receptor Heteromers: INDICATIONS FOR A ROLE OF SYNERGISTIC D1-D3 RECEPTOR INTERACTIONS IN THE STRIATUM
J. Biol. Chem., September 19, 2008; 283(38): 26016 - 26025.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. J. Martin, N. Boucher, C. Brousseau, and J. J. Tremblay
The Orphan Nuclear Receptor NUR77 Regulates Hormone-Induced StAR Transcription in Leydig Cells through Cooperation with Ca2+/Calmodulin-Dependent Protein Kinase I
Mol. Endocrinol., September 1, 2008; 22(9): 2021 - 2037.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Jahn-Schmid, P. Sirven, V. Leb, W. F. Pickl, G. F. Fischer, G. Gadermaier, M. Egger, C. Ebner, F. Ferreira, B. Maillere, et al.
Characterization of HLA Class II/Peptide-TCR Interactions of the Immunodominant T Cell Epitope in Art v 1, the Major Mugwort Pollen Allergen
J. Immunol., September 1, 2008; 181(5): 3636 - 3642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Keller, J. T. Petrie, P. De Rose, I. Gerin, W. S. Wright, S.-H. Chiang, A. R. Nielsen, C. P. Fischer, B. K. Pedersen, and O. A. MacDougald
Fat-specific Protein 27 Regulates Storage of Triacylglycerol
J. Biol. Chem., May 23, 2008; 283(21): 14355 - 14365.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Du, R. L. S. Perry, N. B. Nowacki, J. W. Gordon, J. Salma, J. Zhao, A. Aziz, J. Chan, K. W. M. Siu, and J. C. McDermott
Protein Kinase A Represses Skeletal Myogenesis by Targeting Myocyte Enhancer Factor 2D
Mol. Cell. Biol., May 1, 2008; 28(9): 2952 - 2970.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
R. A. Lew, F. J. Warner, I. Hanchapola, M. A. Yarski, J. Manohar, L. M. Burrell, and A. I. Smith
Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor
Exp Physiol, May 1, 2008; 93(5): 685 - 693.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. L. Padgett and S. C. R. Lummis
The F-loop of the GABAA Receptor {gamma}2 Subunit Contributes to Benzodiazepine Modulation
J. Biol. Chem., February 1, 2008; 283(5): 2702 - 2708.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Sloma, M.-T. Zilber, T. Vasselon, N. Setterblad, M. Cavallari, L. Mori, G. De Libero, D. Charron, N. Mooney, and C. Gelin
Regulation of CD1a Surface Expression and Antigen Presentation by Invariant Chain and Lipid Rafts
J. Immunol., January 15, 2008; 180(2): 980 - 987.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. K. Tan, J. Wang, P.-L. H. Littler, K. K. Wong, T. A. Sweetnam, W. Keefe, N. R. Nash, E. C. Reding, F. Piu, M. R. Brann, et al.
Monitoring Interactions between Receptor Tyrosine Kinases and Their Downstream Effector Proteins in Living Cells Using Bioluminescence Resonance Energy Transfer
Mol. Pharmacol., December 1, 2007; 72(6): 1440 - 1446.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Jollivet, G. Raposo, A. Dimitrov, R. Sougrat, B. Goud, and F. Perez
Analysis of De Novo Golgi Complex Formation after Enzyme-based Inactivation
Mol. Biol. Cell, November 1, 2007; 18(11): 4637 - 4647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Sohy, M. Parmentier, and J.-Y. Springael
Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers
J. Biol. Chem., October 12, 2007; 282(41): 30062 - 30069.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. J. Kueng, V. M. Leb, D. Haiderer, G. Raposo, C. Thery, S. V. Derdak, K. G. Schmetterer, A. Neunkirchner, C. Sillaber, B. Seed, et al.
General Strategy for Decoration of Enveloped Viruses with Functionally Active Lipid-Modified Cytokines
J. Virol., August 15, 2007; 81(16): 8666 - 8676.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Uzan-Gafsou, H. Bausinger, F. Proamer, S. Monier, D. Lipsker, J.-P. Cazenave, B. Goud, H. de la Salle, D. Hanau, and J. Salamero
Rab11A Controls the Biogenesis of Birbeck Granules by Regulating Langerin Recycling and Stability
Mol. Biol. Cell, August 1, 2007; 18(8): 3169 - 3179.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. Araud, R. Genolet, P. Jaquier-Gubler, and J. Curran
Alternatively spliced isoforms of the human elk-1 mRNA within the 5' UTR: implications for ELK-1 expression
Nucleic Acids Res., July 9, 2007; 35(14): 4649 - 4663.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
D. Michod and C. Widmann
TAT-RasGAP317-326 Requires p53 and PUMA to Sensitize Tumor Cells to Genotoxins
Mol. Cancer Res., May 1, 2007; 5(5): 497 - 507.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Cabello, R. Remelli, L. Canela, A. Soriguera, J. Mallol, E. I. Canela, M. J. Robbins, C. Lluis, R. Franco, R. A. J. McIlhinney, et al.
Actin-binding Protein {alpha}-Actinin-1 Interacts with the Metabotropic Glutamate Receptor Type 5b and Modulates the Cell Surface Expression and Function of the Receptor
J. Biol. Chem., April 20, 2007; 282(16): 12143 - 12153.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. P. Heffernan, K. Unsal-Kacmaz, A. N. Heinloth, D. A. Simpson, R. S. Paules, A. Sancar, M. Cordeiro-Stone, and W. K. Kaufmann
Cdc7-Dbf4 and the Human S Checkpoint Response to UVC
J. Biol. Chem., March 30, 2007; 282(13): 9458 - 9468.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
P. A. Nuzzi, M. A. Senetar, and A. Huttenlocher
Asymmetric Localization of Calpain 2 during Neutrophil Chemotaxis
Mol. Biol. Cell, March 1, 2007; 18(3): 795 - 805.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Tchkonia, N. Giorgadze, T. Pirtskhalava, T. Thomou, M. DePonte, A. Koo, R. A. Forse, D. Chinnappan, C. Martin-Ruiz, T. von Zglinicki, et al.
Fat Depot-Specific Characteristics Are Retained in Strains Derived From Single Human Preadipocytes
Diabetes, September 1, 2006; 55(9): 2571 - 2578.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Thompson, C. L. Padgett, and S. C. R. Lummis
Mutagenesis and Molecular Modeling Reveal the Importance of the 5-HT3 Receptor F-loop
J. Biol. Chem., June 16, 2006; 281(24): 16576 - 16582.
[Abstract] [Full Text] [PDF]


Home page
CSH ProtocolsHome page
J. Sambrook and D. W. Russell
Calcium-phosphate-mediated Transfection of Eukaryotic Cells with Plasmid DNAs
CSH Protocols, May 1, 2006; 2006(2): pdb.prot3871 - pdb.prot3871.
[Full Text]


Home page
CSH ProtocolsHome page
J. Sambrook and D. W. Russell
Calcium-phosphate-mediated Transfection of Cells with High-molecular-weight Genomic DNA
CSH Protocols, May 1, 2006; 2006(2): pdb.prot3872 - pdb.prot3872.
[Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Sterling, M. A. Atmodjo, S. E. Inwood, V. S. Kumar Kolli, H. F. Quigley, M. G. Hahn, and D. Mohnen
From the Cover: Functional identification of an Arabidopsis pectin biosynthetic homogalacturonan galacturonosyltransferase
PNAS, March 28, 2006; 103(13): 5236 - 5241.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Farooqui, Z. H. Geng, E. J. Stephenson, N. Zaveri, D. Yee, and K. Gupta
Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells.
Mol. Cancer Ther., March 1, 2006; 5(3): 611 - 620.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Ferrara, F. Stuart, P. Sondermann, P. Brunker, and P. Umana
The Carbohydrate at Fc{gamma}RIIIa Asn-162: AN ELEMENT REQUIRED FOR HIGH AFFINITY BINDING TO NON-FUCOSYLATED IgG GLYCOFORMS
J. Biol. Chem., February 24, 2006; 281(8): 5032 - 5036.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Salvi, E. Castillo, M.-J. Voirol, M. Glauser, J.-P. Rey, R. C. Gaillard, P. Vollenweider, and F. P. Pralong
Gonadotropin-Releasing Hormone-Expressing Neurons Immortalized Conditionally Are Activated by Insulin: Implication of the Mitogen-Activated Protein Kinase Pathway
Endocrinology, February 1, 2006; 147(2): 816 - 826.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
F. Xiao, A. Mirwald, M. Papaioannou, A. Baniahmad, and J. Klug
Secretoglobin 2A1 Is under Selective Androgen Control Mediated by a Peculiar Binding Site for Sp Family Transcription Factors
Mol. Endocrinol., December 1, 2005; 19(12): 2964 - 2978.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Mantegazza and S. Cestele
{beta}-Scorpion toxin effects suggest electrostatic interactions in domain II of voltage-dependent sodium channels
J. Physiol., October 1, 2005; 568(1): 13 - 30.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-Y. Yang, J. Walicki, A. Abderrahmani, M. Cornu, G. Waeber, B. Thorens, and C. Widmann
Expression of an Uncleavable N-terminal RasGAP Fragment in Insulin-secreting Cells Increases Their Resistance toward Apoptotic Stimuli without Affecting Their Glucose-induced Insulin Secretion
J. Biol. Chem., September 23, 2005; 280(38): 32835 - 32842.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-X. Qu, P. Hao, X.-J. Song, S.-M. Jiang, Y.-X. Liu, P.-G. Wang, X. Rao, H.-D. Song, S.-Y. Wang, Y. Zuo, et al.
Identification of Two Critical Amino Acid Residues of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Its Variation in Zoonotic Tropism Transition via a Double Substitution Strategy
J. Biol. Chem., August 19, 2005; 280(33): 29588 - 29595.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J.-Y. Yang, J. Walicki, D. Michod, G. Dubuis, and C. Widmann
Impaired Akt Activity Down-Modulation, Caspase-3 Activation, and Apoptosis in Cells Expressing a Caspase-resistant Mutant of RasGAP at Position 157
Mol. Biol. Cell, August 1, 2005; 16(8): 3511 - 3520.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S. A. Mitchell, K. A. Spriggs, M. Bushell, J. R. Evans, M. Stoneley, J. P.C. Le Quesne, R. V. Spriggs, and A. E. Willis
Identification of a motif that mediates polypyrimidine tract-binding protein-dependent internal ribosome entry
Genes & Dev., July 1, 2005; 19(13): 1556 - 1571.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Thompson, K. L. Price, D. C. Reeves, S. L. Chan, P.-L. Chau, and S. C. R. Lummis
Locating an Antagonist in the 5-HT3 Receptor Binding Site Using Modeling and Radioligand Binding
J. Biol. Chem., May 27, 2005; 280(21): 20476 - 20482.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Baril and L. Brakier-Gingras
Translation of the F protein of hepatitis C virus is initiated at a non-AUG codon in a +1 reading frame relative to the polyprotein
Nucleic Acids Res., March 8, 2005; 33(5): 1474 - 1486.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
G. Tanackovic and A. Kramer
Human Splicing Factor SF3a, but Not SF1, Is Essential for Pre-mRNA Splicing In Vivo
Mol. Biol. Cell, March 1, 2005; 16(3): 1366 - 1377.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. El-Asmar, J.-Y. Springael, S. Ballet, E. U. Andrieu, G. Vassart, and M. Parmentier
Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers
Mol. Pharmacol., February 1, 2005; 67(2): 460 - 469.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Torvinen, D. Marcellino, M. Canals, L. F. Agnati, C. Lluis, R. Franco, and K. Fuxe
Adenosine A2A Receptor and Dopamine D3 Receptor Interactions: Evidence of Functional A2A/D3 Heteromeric Complexes
Mol. Pharmacol., February 1, 2005; 67(2): 400 - 407.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. N. Robinson, K. Manto, R. J. Buchsbaum, J. I. S. MacDonald, and S. O. Meakin
Neurotrophin-dependent Tyrosine Phosphorylation of Ras Guanine-releasing Factor 1 and Associated Neurite Outgrowth Is Dependent on the HIKE Domain of TrkA
J. Biol. Chem., January 7, 2005; 280(1): 225 - 235.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J.-Y. Yang, D. Michod, J. Walicki, B. M. Murphy, S. Kasibhatla, S. J. Martin, and C. Widmann
Partial Cleavage of RasGAP by Caspases Is Required for Cell Survival in Mild Stress Conditions
Mol. Cell. Biol., December 1, 2004; 24(23): 10425 - 10436.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
E. Ilegems, H. M. Pick, and H. Vogel
Downregulation of eRF1 by RNA interference increases mis-acylated tRNA suppression efficiency in human cells
Protein Eng. Des. Sel., December 1, 2004; 17(12): 821 - 827.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Yi, Z. Li, K. Yuan, X. Qu, J. Chen, G. Wang, H. Zhang, H. Luo, L. Zhu, P. Jiang, et al.
Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells
J. Virol., October 15, 2004; 78(20): 11334 - 11339.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Salahpour, S. Angers, J.-F. Mercier, M. Lagace, S. Marullo, and M. Bouvier
Homodimerization of the {beta}2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting
J. Biol. Chem., August 6, 2004; 279(32): 33390 - 33397.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
I. Loiodice, A. Alves, G. Rabut, M. van Overbeek, J. Ellenberg, J.-B. Sibarita, and V. Doye
The Entire Nup107-160 Complex, Including Three New Members, Is Targeted as One Entity to Kinetochores in Mitosis
Mol. Biol. Cell, July 1, 2004; 15(7): 3333 - 3344.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. M. Pickering, S. A. Mitchell, K. A. Spriggs, M. Stoneley, and A. E. Willis
Bag-1 Internal Ribosome Entry Segment Activity Is Promoted by Structural Changes Mediated by Poly(rC) Binding Protein 1 and Recruitment of Polypyrimidine Tract Binding Protein 1
Mol. Cell. Biol., June 15, 2004; 24(12): 5595 - 5605.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Legros, F. Malka, P. Frachon, A. Lombes, and M. Rojo
Organization and dynamics of human mitochondrial DNA
J. Cell Sci., June 1, 2004; 117(13): 2653 - 2662.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Zhu, B. J. Swanson, M. Wang, D. A. Hildeman, B. C. Schaefer, X. Liu, H. Suzuki, K. Mihara, J. Kappler, and P. Marrack
Constitutive association of the proapoptotic protein Bim with Bcl-2-related proteins on mitochondria in T cells
PNAS, May 18, 2004; 101(20): 7681 - 7686.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. L. Doan, S. D. Porter, Z. Duan, M. M. Flubacher, D. Montoya, P. N. Tsichlis, M. Horwitz, C. B. Gilks, and H. L. Grimes
Targeted transcriptional repression of Gfi1 by GFI1 and GFI1B in lymphoid cells
Nucleic Acids Res., May 6, 2004; 32(8): 2508 - 2519.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-T. Chang and A-M. Huang
{alpha}-Pal/NRF-1 Regulates the Promoter of the Human Integrin-associated Protein/CD47 Gene
J. Biol. Chem., April 9, 2004; 279(15): 14542 - 14550.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Steinberger, O. Majdic, S. V. Derdak, K. Pfistershammer, S. Kirchberger, C. Klauser, G. Zlabinger, W. F. Pickl, J. Stockl, and W. Knapp
Molecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-Like Domains
J. Immunol., February 15, 2004; 172(4): 2352 - 2359.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
C. L. JOPLING, K. A. SPRIGGS, S. A. MITCHELL, M. STONELEY, and A. E. WILLIS
L-Myc protein synthesis is initiated by internal ribosome entry
RNA, February 1, 2004; 10(2): 287 - 298.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Unsal-Kacmaz and A. Sancar
Quaternary Structure of ATR and Effects of ATRIP and Replication Protein A on Its DNA Binding and Kinase Activities
Mol. Cell. Biol., February 1, 2004; 24(3): 1292 - 1300.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Buratti, A. F. Muro, M. Giombi, D. Gherbassi, A. Iaconcig, and F. E. Baralle
RNA Folding Affects the Recruitment of SR Proteins by Mouse and Human Polypurinic Enhancer Elements in the Fibronectin EDA Exon
Mol. Cell. Biol., February 1, 2004; 24(3): 1387 - 1400.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Canals, D. Marcellino, F. Fanelli, F. Ciruela, P. de Benedetti, S. R. Goldberg, K. Neve, K. Fuxe, L. F. Agnati, A. S. Woods, et al.
Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization: QUALITATIVE AND QUANTITATIVE ASSESSMENT BY FLUORESCENCE AND BIOLUMINESCENCE ENERGY TRANSFER
J. Biol. Chem., November 21, 2003; 278(47): 46741 - 46749.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
F. Chimienti, R. C. Hogg, L. Plantard, C. Lehmann, N. Brakch, J. Fischer, M. Huber, D. Bertrand, and D. Hohl
Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda
Hum. Mol. Genet., November 15, 2003; 12(22): 3017 - 3024.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
M. BARIL, D. DULUDE, K. GENDRON, G. LEMAY, and L. BRAKIER-GINGRAS
Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M
RNA, October 1, 2003; 9(10): 1246 - 1253.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. L. Thompson, C. B. Rickman, S. J. Shaw, J. N. Ebright, U. Kelly, A. Sancar, and D. W. Rickman
Expression of the Blue-Light Receptor Cryptochrome in the Human Retina
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4515 - 4521.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Burgueno, D. J. Blake, M. A. Benson, C. L. Tinsley, C. T. Esapa, E. I. Canela, P. Penela, J. Mallol, F. Mayor Jr., C. Lluis, et al.
The Adenosine A2A Receptor Interacts with the Actin-binding Protein {alpha}-Actinin
J. Biol. Chem., September 26, 2003; 278(39): 37545 - 37552.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Kovacs, M. Steinmann, P. J. Magistretti, O. Halfon, and J.-R. Cardinaux
CCAAT/Enhancer-binding Protein Family Members Recruit the Coactivator CREB-binding Protein and Trigger Its Phosphorylation
J. Biol. Chem., September 19, 2003; 278(38): 36959 - 36965.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Chen, L. Smith, Z. Wang, and J. B. Smith
Preservation of Caspase-3 Subunits from Degradation Contributes to Apoptosis Evoked by Lactacystin: Any Single Lysine or Lysine Pair of the Small Subunit Is Sufficient for Ubiquitination
Mol. Pharmacol., August 1, 2003; 64(2): 334 - 345.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ogrunc and A. Sancar
Identification and Characterization of Human MUS81-MMS4 Structure-specific Endonuclease
J. Biol. Chem., June 6, 2003; 278(24): 21715 - 21720.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. R. Brandt, A. W. Kolb, D. D. Shah, A. M. Pumfery, R. L. Kintner, E. Jaehnig, and J. J. Van Gompel
Multiple Determinants Contribute to the Virulence of HSV Ocular and CNS Infection and Identification of Serine 34 of the US1 Gene as an Ocular Disease Determinant
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2657 - 2668.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Chantalat, R. Courbeyrette, F. Senic-Matuglia, C. L. Jackson, B. Goud, and A. Peyroche
A Novel Golgi Membrane Protein Is a Partner of the ARF Exchange Factors Gea1p and Gea2p
Mol. Biol. Cell, June 1, 2003; 14(6): 2357 - 2371.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Nakamura, M. Sano, Z. Songyang, and M. D. Schneider
A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis
PNAS, May 13, 2003; 100(10): 5834 - 5839.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
N. Petit, A. Lescure, M. Rederstorff, A. Krol, B. Moghadaszadeh, U. M. Wewer, and P. Guicheney
Selenoprotein N: an endoplasmic reticulum glycoprotein with an early developmental expression pattern
Hum. Mol. Genet., May 1, 2003; 12(9): 1045 - 1053.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. K. Seabold, A. Burette, I. A. Lim, R. J. Weinberg, and J. W. Hell
Interaction of the Tyrosine Kinase Pyk2 with the N-Methyl-D-aspartate Receptor Complex via the Src Homology 3 Domains of PSD-95 and SAP102
J. Biol. Chem., April 18, 2003; 278(17): 15040 - 15048.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Dulude, M. Baril, and L. Brakier-Gingras
Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1
Nucleic Acids Res., December 1, 2002; 30(23): 5094 - 5102.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
F. Legros, A. Lombes, P. Frachon, and M. Rojo
Mitochondrial Fusion in Human Cells Is Efficient, Requires the Inner Membrane Potential, and Is Mediated by Mitofusins
Mol. Biol. Cell, December 1, 2002; 13(12): 4343 - 4354.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Smith and J. B. Smith
Lack of Constitutive Activity of the Free Kinase Domain of Protein Kinase C zeta . DEPENDENCE ON TRANSPHOSPHORYLATION OF THE ACTIVATION LOOP
J. Biol. Chem., November 22, 2002; 277(48): 45866 - 45873.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
W. El-Sankary, V. Bombail, G. G. Gibson, and N. Plant
Glucocorticoid-Mediated Induction of CYP3A4 is Decreased by Disruption of a Protein: DNA Interaction Distinct from the Pregnane X Receptor Response Element
Drug Metab. Dispos., September 1, 2002; 30(9): 1029 - 1034.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Bennin, A. S. A. Don, T. Brake, J. L. McKenzie, H. Rosenbaum, L. Ortiz, A. A. DePaoli-Roach, and M. C. Horne
Cyclin G2 Associates with Protein Phosphatase 2A Catalytic and Regulatory B' Subunits in Active Complexes and Induces Nuclear Aberrations and a G1/S Phase Cell Cycle Arrest
J. Biol. Chem., July 19, 2002; 277(30): 27449 - 27467.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A.-L. Ducrest, M. Amacker, J. Lingner, and M. Nabholz
Detection of promoter activity by flow cytometric analysis of GFP reporter expression
Nucleic Acids Res., July 15, 2002; 30(14): e65 - e65.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
D. L. Cioffi, T. M. Moore, J. Schaack, J. R. Creighton, D. M.F. Cooper, and T. Stevens
Dominant regulation of interendothelial cell gap formation by calcium-inhibited type 6 adenylyl cyclase
J. Cell Biol., June 24, 2002; 157(7): 1267 - 1278.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yang, B. Dong, P. R. Mittelstadt, H. Xiao, and J. D. Ashwell
HIV Tat Binds Egr Proteins and Enhances Egr-dependent Transactivation of the Fas Ligand Promoter
J. Biol. Chem., May 24, 2002; 277(22): 19482 - 19487.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Ibberson, B. M. Riederer, M. Uldry, B. Guhl, J. Roth, and B. Thorens
Immunolocalization of GLUTX1 in the Testis and to Specific Brain Areas and Vasopressin- Containing Neurons
Endocrinology, January 1, 2002; 143(1): 276 - 284.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
W. El-Sankary, G. G. Gibson, A. Ayrton, and N. Plant
Use of a Reporter Gene Assay to Predict and Rank the Potency and Efficacy of CYP3A4 Inducers
Drug Metab. Dispos., November 1, 2001; 29(11): 1499 - 1504.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A.-L. Ducrest, M. Amacker, Y. D. Mathieu, A. P. Cuthbert, D. A. Trott, R. F. Newbold, M. Nabholz, and J. Lingner
Regulation of Human Telomerase Activity: Repression by Normal Chromosome 3 Abolishes Nuclear Telomerase Reverse Transcriptase Transcripts but Does Not Affect c-Myc Activity
Cancer Res., October 1, 2001; 61(20): 7594 - 7602.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. A. Lindsey-Boltz, V. P. Bermudez, J. Hurwitz, and A. Sancar
Purification and characterization of human DNA damage checkpoint Rad complexes
PNAS, September 25, 2001; 98(20): 11236 - 11241.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
S. Cestele, T. Scheuer, M. Mantegazza, H. Rochat, and W. A. Catterall
Neutralization of Gating Charges in Domain II of the Sodium Channel {alpha} Subunit Enhances Voltage-Sensor Trapping by a {beta}-Scorpion Toxin
J. Gen. Physiol., September 1, 2001; 118(3): 291 - 302.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
T. C. Rich, T. E. Tse, J. G. Rohan, J. Schaack, and J. W. Karpen
In Vivo Assessment of Local Phosphodiesterase Activity Using Tailored Cyclic Nucleotide-Gated Channels as Camp Sensors
J. Gen. Physiol., July 1, 2001; 118(1): 63 - 78.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Yu, V. Hebbar, D. W. Kim, S. Mandlekar, J. M. Pezzuto, and A.-N. T. Kong
Resveratrol Inhibits Phorbol Ester and UV-Induced Activator Protein 1 Activation by Interfering with Mitogen-Activated Protein Kinase Pathways
Mol. Pharmacol., July 1, 2001; 60(1): 217 - 224.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
K. Jeyaseelan, D. Ma, and A. Armugam
Real-time detection of gene promoter activity: quantitation of toxin gene transcription
Nucleic Acids Res., June 15, 2001; 29(12): e58 - e58.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. A. Mitchell, E. C. Brown, M. J. Coldwell, R. J. Jackson, and A. E. Willis
Protein Factor Requirements of the Apaf-1 Internal Ribosome Entry Segment: Roles of Polypyrimidine Tract Binding Protein and upstream of N-ras
Mol. Cell. Biol., May 15, 2001; 21(10): 3364 - 3374.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
D. J. Orlicky and J. Schaack
Adenovirus transduction of 3T3-L1 cells
J. Lipid Res., March 1, 2001; 42(3): 460 - 466.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. M. Roman, R. L. Smith, A. P. Feranchak, G. H. Clayton, R. B. Doctor, and J. G. Fitz
ClC-2 chloride channels contribute to HTC cell volume homeostasis
Am J Physiol Gastrointest Liver Physiol, March 1, 2001; 280(3): G344 - G353.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Herrera, V. Casadó, F. Ciruela, P. Schofield, J. Mallol, C. Lluis, and R. Franco
Adenosine A2B Receptors Behave as an Alternative Anchoring Protein for Cell Surface Adenosine Deaminase in Lymphocytes and Cultured Cells
Mol. Pharmacol., January 1, 2001; 59(1): 127 - 134.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
W. El-Sankary, N. J. Plant, G. G. Gibson, and D. J. Moore
Regulation of the CYP3A4 Gene by Hydrocortisone and Xenobiotics: Role of the Glucocorticoid and Pregnane X Receptors
Drug Metab. Dispos., May 1, 2000; 28(5): 493 - 496.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
A. Bollig and R. J. Miksicek
An Estrogen Receptor-{alpha} Splicing Variant Mediates Both Positive and Negative Effects on Gene Transcription
Mol. Endocrinol., May 1, 2000; 14(5): 634 - 649.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
R. Yu, S. Mandlekar, S. Ruben, J. Ni, and A-N. T. Kong
Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Androgen-independent Prostate Cancer Cells
Cancer Res., May 1, 2000; 60(9): 2384 - 2389.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (104K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (335)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Jordan, M
Right arrow Articles by Wurm, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jordan, M
Right arrow Articles by Wurm, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?